9 METERS BIOPHARMA, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
9 Meters Biopharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q1 2023.
  • 9 Meters Biopharma, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$1.08M, a 8741% decline year-over-year.
  • 9 Meters Biopharma, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$2.84M, a 10627% decline year-over-year.
  • 9 Meters Biopharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.75M, a 9907% decline from 2021.
  • 9 Meters Biopharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$17.5K, a 97.2% increase from 2020.
  • 9 Meters Biopharma, Inc. annual Nonoperating Income (Expense) for 2020 was -$619K, a 58.8% increase from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$2.84M -$1.08M -$1.09M -8741% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$1.75M -$1.19M -$1.2M -12330% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-28
Q3 2022 -$551K -$639K -$638K -111364% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $87K $65.3K +$60K +1121% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $27K $12.5K +$44.5K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$17.5K $9.72K +$197K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-28
Q3 2021 -$214K -$573* +$2.03M +100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$2.24M $5.35K -$236K -97.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$2.01M -$32K -$1.39M -102% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$619K -$187K +$113K +37.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$731K -$2.03M +$684K +25.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.42M $241K -$1.39M -85.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$21.7K $1.36M +$1.48M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$1.5M -$300K +$172K +36.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$1.67M -$2.71M -$1.72M -173% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $45.3K $1.63M +$2.47M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$2.43M -$122K +$3.51M +96.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$5.94M -$472K -$317K -205% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$5.62M -$996K -$885K -801% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$4.74M -$839K -$740K -744% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$4M -$3.63M -$3.56M -4968% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$436K -$155K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$111K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$99.5K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$71.6K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.